(ARQL:Consolidated Issue listed on NASDAQ Global Market)
Patrick J. Zenner MBA
Chairman, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee, ArQule Inc.
|Age||Total Calculated Compensation||This person is connected to 109 board members in 7 different organizations across 12 different industries.|
See Board Relationships
Mr. Patrick J. Zenner, also known as Pat, MBA, served as the President and Chief Executive Officer of Hoffmann-La Roche Inc. from 1993 to January 2001. Mr. Zenner served as Chief Executive Officer of Curagen Corp. from May 23, 2005 to March 2006 and also served as its Interim Chief Executive Officer since May 12, 2005. He served as an Interim Chief Executive Officer at EXACT Sciences Corp. from July 2007 to March 2008. Mr. Zenner served in various other capacities with ...
19 Presidential WayPhone: 781-994-0300
Woburn, Massachusetts 01801
Board Members Memberships*
Independent Director, Member of Audit Committee and Member of Corporate Governance & Nominating Committee
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Director and Member of Compensation Committee
Chairman, Member of Audit Committee and Member of Compensation, Nominating & Governance Committee
Former Independent Director and Chairman of Audit Committee
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Executive Chairman, Member of Compensation Committee and Member of Innovation & Technology Committee
Former Director, Member of Compensation & Management Development Committee and Member of Corporate Development Review Committee
Fairleigh Dickinson University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Ali Fattaey Ph.D.||Chief Executive Officer, President and Director|
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|Raul R. Rodriguez||Chief Executive Officer, President and Director|
Rigel Pharmaceuticals, Inc.
|Michael P. Bailey||Chief Executive Officer, President, Principal Financial Officer and Director|
AVEO Pharmaceuticals, Inc.
|Myung-Joong Cho Ph.D.||Founder, Chief Executive Officer and President|
|--||Compensation as of Fiscal Year 2013.|